S. Wedderburn

The new genomic medicine service and implications for patients .

J. Barwell, K. Snape, S. Wedderburn, 2019, Clinical medicine.

Identification of LAMA1 mutations ends diagnostic odyssey and has prognostic implications for patients with presumed Joubert syndrome

J. Clayton-Smith, U. Kini, E. Boltshauser, 2021, Brain communications.

Towards establishing consistency in triage in a tertiary specialty

M. Porteous, S. Lynch, D. Donnelly, 2019, European Journal of Human Genetics.

Genome sequencing with gene panel-based analysis for rare inherited conditions in a publicly funded healthcare system: implications for future testing

Sancha Martin, E. Tobias, A. Biankin, 2022, European Journal of Human Genetics.

Should All Individuals Be Screened for Genetic Predisposition to Cancer?

T. McVeigh, S. Wedderburn, 2021, Genetics research.

Expanding the phenotypic spectrum of Chromosome16p13.11 microduplication: A multicentric analysis of 206 patients.

C. Mercer, R. McGowan, J. Carmichael, 2023, European journal of medical genetics.

Survival from malignant mesothelioma: where are we now?

K. Kerr, H. Bayes, G. Currie, 2015, The journal of the Royal College of Physicians of Edinburgh.

Update: variable implementation of the 2018 UKCGG/UKGTN guidelines for breast cancer gene panel tests offered by UK genetics services

H. Hanson, M. Tischkowitz, S. Archer, 2021, Journal of Medical Genetics.

Grampian Health Board's joint drug formulary.

J. Webster, B. Jappy, A. Williams, 1990, BMJ.